Effect of the duration of protease inhibitor therapy in HIV-infected individuals on the severity of obstructive sleep apnea

BACKGROUND: Protease inhibitors (PIs) are a vital part of the antiretroviral therapy. Long-term use of PIs may cause lipodystrophy, a clinical syndrome characterized by peripheral lipoatrophy and central fat accumulation, which may increase the risk of developing obstructive sleep apnea (OSA) in HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdeen, Yazan, Al-Halawani, Moh’d, Kaako, Ahmad, Hao, Ingrid Fang Ying, Dazley, Jason, Katpally, Ram, Klukowicz, Alan, Miller, Richard, Slim, Jihad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669999/
https://www.ncbi.nlm.nih.gov/pubmed/31523251
http://dx.doi.org/10.4103/jrms.JRMS_892_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669999/
https://www.ncbi.nlm.nih.gov/pubmed/31523251
http://dx.doi.org/10.4103/jrms.JRMS_892_17

Ejemplares similares